Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.
New England Journal of Medicine.
Times cited: 1158
Adjuvant trastuzumab: A milestone in the treatment of HER-2-positive early breast cancer.
Times cited: 158
Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: A survival study.
Journal of Clinical Oncology.
Times cited: 538